RGLS

Regulus Therapeutics
RGLS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

24 hedge funds and large institutions have $6.37M invested in Regulus Therapeutics in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
24
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$344K
2
+$92K
3
+$62.6K

Top Sellers

1
-$755K
2
-$18.5K
3
-$12K
4
Verition Fund Management
Verition Fund Management
Connecticut
-$10K
5
UBS Group
UBS Group
Switzerland
-$7.34K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.83M
2
$1.81M
3
$1.65M
4
$425K
5
$344K
6
$98K
7
$57K
8
$43K
9
$29K
10
$19K
11
$14K
12
$14K
13
$13K
14
$9K
15
$7K
16
$6K
17
$2K
18
$1K
19
$148
20
–
21
–
22
–
23
–